Trial Profile
The role of acute combined peroxisome proliferator-activated receptors alpha and gamma stimulation on insulin action in humans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 Jun 2017 Status changed from active, no longer recruiting to completed.
- 07 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Mar 2012 Additional lead trial centre and investigator (Meredith Hawkins) identified as reported by ClinicalTrials.gov.